-
ONCR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
Oncorus (ONCR)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.65 mm | 24.65 mm | 24.65 mm | 24.65 mm | 24.65 mm | 24.65 mm |
Cash burn (monthly) | 1.50 mm | 4.52 mm | 9.90 mm | 7.37 mm | 5.82 mm | 4.64 mm |
Cash used (since last report) | 31.12 mm | 94.03 mm | 205.78 mm | 153.14 mm | 120.87 mm | 96.46 mm |
Cash remaining | -6.46 mm | -69.37 mm | -181.12 mm | -128.49 mm | -96.21 mm | -71.81 mm |
Runway (months of cash) | -4.3 | -15.3 | -18.3 | -17.4 | -16.5 | -15.5 |
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 0 |
Closed positions | 27 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 253.96 mm |
Total shares | 12.32 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MPM Asset Management | 2.85 mm | $115.40 mm |
K2 HealthVentures Equity Trust | 2.59 mm | $4.54 mm |
MPM BioVentures 2014 | 2.40 mm | $37.31 mm |
MPM Oncology Impact Management | 2.38 mm | $96.27 mm |
Arkin Moshe | 1.07 mm | $0.00 |
Flynn James E | 1.02 mm | $426.00 k |
BCS Barclays | 9.49 k | $0.00 |
Your Advocates | 100.00 | $4.00 k |